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Attention-deficit/hyperactivity disorder (ADHD) is a recognized serious mental disorder 
that often persists into adulthood. The symptoms and impairments associated with 
ADHD often cause significant mental suffering in affected individuals. ADHD has been 
associated with abnormal neuronal activity in various neuronal circuits, such as the dor-
sofrontostriatal, orbitofrontostriatal, and frontocerebellar circuits. Psychopharmacological 
treatment with methylphenidate hydrochloride is recommended as the first-line treatment 
for ADHD. It is assumed that medication ameliorates ADHD symptoms by improving 
the functioning of the brain areas affected in the condition. However, side effects, con-
traindications, or non-response can limit the effectiveness of a psychopharmacological 
treatment for ADHD. It is therefore necessary to develop non-pharmacological inter-
ventions that target neuronal mechanisms associated with the condition in the same 
way as pharmacological treatment. We think that mindfulness meditation employed as a 
neuropsychotherapeutic intervention could help patients with ADHD to regulate impaired 
brain functioning and thereby reduce ADHD symptoms. In this paper, we highlight the 
mechanisms of such mindfulness meditation, and thus provide a rationale for further 
research and treatment development from a neuropsychotherapeutic perspective. We 
conclude that mindfulness meditation employed as a neuropsychotherapeutic interven-
tion in therapy is a promising treatment approach in ADHD.
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cUrreNt stAte OF treAtMeNt OF ADHD iN ADULtHOOD
Attention deficit/hyperactivity disorder (ADHD) is a serious mental disorder characterized by three 
core symptoms: inattention, impulsivity, and hyperactivity. In up to 60% of cases, ADHD symptoms 
persist into adulthood (1). It has been estimated that about 3.4% of the adult population is affected by 
ADHD (2). The clinical picture of the condition is quite heterogeneous with respect to the expression 
and severity of symptoms, as well as its pathogenesis (3, 4).
It is assumed that the disorder relies strongly on impairments to neurobiological function (5, 6). 
Individuals with ADHD show abnormal neuronal activity in dorsofrontostriatal, orbitofrontostri-
atal, and frontocerebellar circuits (6). Furthermore, abnormal functional connectivity in the default-
mode network (DMN) has been suggested (7).
Adults with ADHD often suffer from comorbid disorders (e.g., depression or anxiety disorders) 
and negative psychosocial consequences (8). Therefore, a multimodal treatment approach that takes 
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into consideration both the ADHD and the comorbid disorders 
and psychosocial functioning is currently the gold standard in the 
treatment of adult ADHD (9).
Psychopharmacological treatment with methylphenidate 
hydrochloride is recommended as the first-line treatment for 
ADHD core symptoms (9). Methylphenidate influences dopa-
minergic and noradrenergic systems of the striatum, prefrontal 
cortex, locus coeruleus, and somatosensory cortex. Dopamine 
plays an important role in drive and motivation, and noradrenalin 
in attentional processes (10–12). Therefore, it has been suggested 
that the positive effects of methylphenidate on ADHD can be 
attributed to improving the functioning of brain areas involved 
in attentional and motivational processes (13). These positive 
effects can be augmented when combined with individual or 
group cognitive behavioral therapy (14).
However, while psychopharmacological treatment with 
methylphenidate has undoubted positive effects on ADHD 
symptoms, it also has significant limitations. About 20–50% of 
adult ADHD patients are non-responders (15). Also, a study by 
Tucha et al. (16) showed that although methylphenidate reduced 
deficits in attentional processes, it did not achieve normaliza-
tion. Furthermore, contraindications such as hyperthyroidism, 
pregnancy, hypertonia, or substance abuse can prohibit treat-
ment with methylphenidate (9, 17, 18). For instance, in a study 
investigating the efficacy of a combination of cognitive behav-
ioral group psychotherapy, individual clinical management, and 
methylphenidate in a clinical sample, contraindications in about 
20% of participants meant that they could not be treated with 
methylphenidate (14). Even if treatment with methylphenidate 
is possible, adverse side effects can occur. These most frequently 
include headaches, loss of appetite and weight, insomnia, internal 
unrest, and increased blood pressure and pulse (10). As a result, 
some patients prefer non-medical treatment.
Given the limitations of treatment with methylphenidate, 
it is worth considering alternative treatment approaches that 
target both the underlying neurobiological mechanisms and 
the psychosocial difficulties of patients with ADHD. From our 
point of view, this is best achieved by administering treatment 
from a neuropsychotherapeutic perspective. Such an approach 
incorporates neurobehavioral interventions to enhance the 
functioning of brain regions affected in ADHD and specific cog-
nitive behavioral interventions. In mindfulness-based cognitive 
therapy (MBCT), conventional cognitive behavioral interven-
tions are combined with mindfulness meditation, which can 
be understood as a form of mental training (19). Mindfulness 
signifies an open and alert state of mind. The person’s attention 
stays in the present moment, and sensations such as thoughts and 
feelings that arise are perceived and observed  non-judgmentally 
(20). There is preliminary evidence that mindfulness meditation 
can improve the functioning of brain mechanisms underlying 
neuropsychological capacities impaired in ADHD, such as 
attention control and emotion regulation (19). We think that 
mindfulness meditation in patients with ADHD could help 
them to regulate brain functioning and thereby ameliorate their 
symptoms.
This paper aims to illustrate our concept of a neuropsycho-
therapeutic approach for ADHD in adulthood.
A search for trials on treatment, mindfulness, neuropsycho-
therapy, and psychotherapy in adult ADHD was conducted in the 
following bibliographic databases: PubMed, Embase, Medline, 
and Central (The Cochrane Central Register of Controlled 
Trials). The following terms were used: (ADHD OR (attention 
deficit) OR (attention deficit) OR hyperactivity*) AND (non-
psychopharmacological treatment OR treatment OR therapy 
OR mindfulness OR psychotherapy OR neuropsychotherapy 
OR neuropsychology) AND (adult). Studies were selected and 
included according to their relevance for the subject.
WHAt is NeUrOPsYcHOtHerAPY?
The concept of neuropsychotherapy represents the link between 
neuropsychology and psychotherapy. A neuropsychotherapeutic 
approach brings a neuroscientific perspective to therapeutic 
issues and aims to target underlying brain mechanisms that could 
be an obstacle to recovery in traditional therapy (21, 22).
We define “neuropsychotherapy” as an approach that integrates 
cognitive behavioral therapy with neurobehavioral treatment. 
Neurobehavioral treatment refers to behavioral interventions 
that deliberately target neuronal mechanisms associated with 
psychiatric disorders, in the same way as pharmacological or 
surgical treatments (22).
Since neuropsychotherapy targets neurobiological mecha-
nisms, as well as observable symptoms or cognitive, behavioral 
manifestations of underlying neurobiological mechanisms, mul-
tiple therapeutic interventions are used. As in conventional psy-
chotherapy, cognitive and behavioral interventions are employed 
for psychoeducative purposes and to bring about change in 
problematic cognitive and behavioral patterns. In addition, neu-
ropsychological interventions are used. That is, affected neuronal 
structures are identified through neuropsychological assessment 
and neuroimaging. Subsequently, neurobehavioral interventions 
are employed to strengthen the functioning of those neuronal 
structures via concrete, intensive, and repetitive stimulation (21).
There is evidence that intensive and repetitive targeting of 
dysfunctional neuronal structures can ameliorate psychiatric dis-
orders and improve brain functioning. In one study, patients with 
severe unipolar depression received neurobehavioral “cognitive 
control training” for 2 weeks, aimed at activating the prefrontal 
cortex, which it has been suggested plays an important role in 
depressive symptoms such as rumination. They were compared to 
a control group who received treatment as usual. Participants in 
the intervention group displayed a significantly greater decrease 
in depressive symptoms and rumination than participants in the 
control group. In addition, participants who received the cogni-
tive control training showed normalization of brain functions 
targeted by the intervention (22).
Furthermore, it has been proposed that the success of cognitive 
behavioral therapy in treating anxiety disorders may be attribut-
able to the modification of underlying, dysfunctional neuronal 
systems, as a result of the concrete, intense, and repetitive stimula-
tion induced by exposure sessions (21). For instance, neuroim-
aging studies in OCD (obsessive compulsive disorder) samples 
(23,  24) revealed that exposure is associated with improved 
activity in brain areas involved in obsessive compulsive behavior.
FiGUre 1 | cerebellar pathways affected in ADHD.
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It is recognized that, owing to neuronal plasticity, altered brain 
functioning can be modified by intense, prolonged, and regular 
therapeutic interventions (21, 22, 25), leading to improved 
psychological functioning. Therefore, the neuroscientifically 
informed implementation of neurobehavioral interventions in 
conventional psychotherapy appears to be a promising approach 
to improving treatment outcomes (22). It would appear particu-
larly promising for treatment of a condition such as ADHD, which 
is known to be significantly related to structural, functional, and 
neurochemical brain abnormalities (26).
WHY NeUrOPsYcHOtHerAPY iN ADHD?
There is growing evidence that ADHD psychopathology is 
closely related to dysfunctions in multiple neuronal systems 
implicated in higher-level cognitive functions, as well as senso-
rimotor processes and the DMN (a brain network that is active 
in the resting state and inactive during task performance), which 
causes impairments in executive functioning (26), including in 
attentional processes such as sustained attention and set-shifting, 
impulse control, and working memory. ADHD symptoms are 
thought to reflect altered connectivity within and among several 
neural networks, rather than abnormal functioning of discrete, 
isolated brain regions (5). It has been suggested that mostly 
prefrontal–striatal–cerebellar circuits are impaired in ADHD 
in adulthood, specifically the prefrontal cortex, basal ganglia, 
and cerebellum are associated with ADHD (27, 28). The first of 
these neural circuits are frontostriatal loops, involved in response 
output control/response suppression, working memory, and 
response selection. Impairments are also found in frontocerebel-
lar loops, responsible for the temporal information processing 
needed in timing and alerting the brain to new information. 
Finally, frontolimbic loops involved in avoidance conditioning 
and reinforcement learning are relevant to ADHD (27) (see 
Figure 1).
Frontoparietal Network
A meta-analysis of neuroimaging studies of ADHD in adulthood 
revealed ADHD-related hypoactivation located in the frontopa-
rietal network, which includes the lateral frontal pole, anterior 
cingulate cortex (ACC), dorsolateral prefrontal cortex (dlPFC), 
anterior PFC (aPFC), lateral cerebellum, anterior insula, and 
the caudate and inferior parietal lobe (5, 29). The frontoparietal 
network is known as the executive control circuit (30). It guides 
decision making by integrating external information with internal 
representations (5). It provides the flexibility to configure infor-
mation processing when task demands change, and is involved 
in goal-directed executive processes (31). Hypoactivation in the 
frontoparietal network is consistent with executive dysfunction 
in ADHD in adulthood (26).
Attentional Network
The functioning of the dorsal and ventral attentional networks, 
which are central parts of the attentional regulatory system, 
also seems to be impaired in ADHD (5, 32). The ventral 
attentional network includes the temporoparietal junction, 
the supramarginal gyrus, frontal operculum, and anterior 
insula (32). It is involved in attentional reorienting to relevant 
external stimuli and in interrupting ongoing activity when 
necessary. To prevent shifts of attention to irrelevant objects, 
suppression of this network is needed (33). It has been sug-
gested that hyperactivation of the ventral attentional network 
may explain distractibility, which is a main symptom of ADHD 
(26). The dorsal attentional network, which is anchored by 
the intraparietal sulcus and the frontal eye fields, also shows 
ADHD-related abnormalities. The dorsal attentional network 
is associated with attention shifting and the control of spatial 
attention (32).
visual and Motor Network
Furthermore, impairments in the visual network have been 
proposed (34). This network includes the visual cortex and the 
middle temporal area complex, both of which are connected to 
the dorsal attentional network. The middle temporal area com-
plex is also functionally correlated to frontal regions, as well as to 
primary visual areas (5, 35).
There is also evidence that the motor network (e.g., primary 
motor cortex, primary sensory cortex, putamen, thalamus, and 
cerebellum) may be affected in ADHD (5).
Default-Mode Network
Attention deficit/hyperactivity disorder has also been con-
ceptualized as a disorder of dysfunctional DMN activity. The 
DMN includes the medial prefrontal cortex (mPFC), ACC, and 
posterior cingulate cortex (PCC) (36). It has been suggested 
that in ADHD the inter-regulation between the DMN and 
networks activated during task performance (e.g., frontoparietal, 
ventral, or dorsal attentional networks) is disturbed. During task 
performance, DMN activity is typically suppressed. According 
to one hypothesis, in ADHD the DMN is hyperactive during 
task performance, which may cause the disruption in cognitive 
performance and fluctuation in attention that characterize the 
condition (26, 37). For example, the regulation of DMN activity 
by stimulant medication has been shown to improve cognitive 
performance in ADHD (38, 39).
Given these neurobiological functional impairments in 
ADHD, it seems rational to employ principles of neuroscience in 
treatment, which we discuss next.
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MiNDFULNess-BAseD cOGNitive 
tHerAPY FrOM A 
NeUrOPsYcHOtHerAPeUtic 
PersPective
A promising approach to improve the outcome of therapy in 
ADHD involves the neuropsychotherapeutic administration 
of meditation practice in MBCT. MBCT combines methods of 
cognitive behavioral therapy with mindfulness meditation. The 
treatment aims to provide the patient with an explanation for 
his symptoms, as well as information about ADHD. Behavioral 
interventions are designed to develop planning skills such as 
time management or problem solving. With cognitive methods, 
patients learn to identify and modify problematic thinking pat-
terns (40). Besides cognitive behavioral interventions, patients 
engage in mindfulness meditation, which can be defined as a form 
of mental training that can improve neuropsychological deficits 
in ADHD, such as attention control and emotion regulation, by 
strengthening the function of brain regions believed to underlie 
these deficits (19).
It has been proposed that mindfulness meditation can help 
reduce mind wandering and distractibility in ADHD by improv-
ing the functioning of the DMN. For example, experienced medi-
tators show reduced activation of the DMN during meditation 
and stronger functional connectivity of brain regions implicated 
in cognitive control and self-monitoring (41).
A further possible beneficial effect of mindfulness meditation 
in ADHD is that it teaches patients not to act out but rather to 
observe emotional states as temporary and passing events, thereby 
helping patients to improve their regulation of emotion. Emotion 
regulation refers to strategies that help to exert influence on the 
occurrence, experience, and expression of emotions (19,  42). 
Even though emotional dysregulation is not a core diagnostic 
feature of ADHD, it often contributes to considerable impairment 
(43–45). Neuroimaging studies have found neuroplastic changes 
in the structure and function of brain regions supporting emotion 
regulation (19).
The neurobiological mechanism of mindfulness meditation 
is currently not fully understood. It has been hypothesized that 
mindfulness meditation changes brain structure and function 
by myelinogenesis, synaptogenesis, dendritic branching, or 
adult neurogenesis (19). Furthermore, it seems possible that 
 mindfulness meditation has a positive effect on neuronal preser-
vation, restoration, and/or inhibition of apoptosis (46–48).
Besides these findings from neuroimaging studies, treat-
ment studies have provided promising preliminary support for 
the feasibility and acceptability of mindfulness meditation in 
the treatment of ADHD. Recent studies indicate that mindful-
ness meditation training has ameliorating effects on ADHD 
symptoms and improves executive functioning, as well as 
emotion regulation (ISRCTN12722296 in preparation) (49, 50). 
Furthermore, participants show notable levels of compliance and 
report a high degree of satisfaction with the treatment (51). In 
addition, mindfulness meditation is a core component of a modi-
fied Dialectical Behavior Therapy group program for adults with 
ADHD. Mindfulness meditation seems to be well accepted by the 
patients and a very useful component of the program (52, 53) 
(see Table 1).
Given this evidence, we conclude that engagement in 
mindfulness meditation is associated with functional changes 
in brain areas suggested to be impaired in adults with ADHD. 
In addition, patients readily accept mindfulness meditation. 
Thus, mindfulness meditation appears to be a promising 
neurobehavioral intervention, with several potential pathways 
to improving neuropsychological functioning in patients with 
ADHD.
LiMitAtiONs AND iMPLicAtiONs  
FOr FUtUre reseArcH
There is emerging evidence that mindfulness meditation ame-
liorates ADHD symptoms and may cause neuroplastic changes 
in brain regions impaired in ADHD. However, the study of the 
neurobiological mechanisms of mindfulness meditation and its 
beneficial effects in ADHD is still in its infancy. This allows only 
speculative statements about possible future treatment direc-
tions. The following limitations have to be considered, along with 
recommendations arising out of them.
Research is needed that uses larger sample sizes, active con-
trol conditions, and longitudinal, randomized research designs 
(19, 51).
To our knowledge, no neuroimaging study has investigated 
the effects of mindfulness meditation on the adult ADHD brain. 
Future research should aim to expand understanding of the 
neurobiological effects of mindfulness meditation in ADHD and 
to connect neuroscientific findings with behavioral data.
Furthermore, it has been suggested that ADHD is a hetero-
geneous condition, which probably includes different diagnostic 
subtypes (54), possibly caused by different neurobiological 
impairments. In addition, owing to the high comorbidity with 
other psychiatric disorders, common comorbid psychiatric disor-
ders may rely on the same dysfunctional neuronal mechanisms as 
ADHD does. For example, ADHD and bipolar disorder show an 
overlap in diagnostic criteria, such as inattention and irritability 
(55). Also, a significantly higher prevalence of ADHD among 
relatives of persons with bipolar disorder and a  significantly 
higher prevalence of bipolar I disorder among relatives of per-
sons with ADHD has been reported (56). This co-occurrence 
may be associated with impairments in the same underlying 
neuronal mechanisms. Knowledge of these underlying neuronal 
mechanisms could help in developing a more specific assessment 
and classification of psychiatric disorders, as well as improved 
treatment interventions.
Another area for future research is investigation of the opti-
mum amount of mindfulness meditation practice in ADHD. 
Neurobehavioral interventions are known to involve intense, 
prolonged, and regular stimulation of the targeted brain areas to 
effectively change neuronal structures (21). However, it is as yet 
not known how much mindfulness meditation is needed to evoke 
changes in neuroplasticity and psychological functioning in 
tABLe 1 | evidence of changes after mindfulness meditation.
reference sample Mean  
age
Duration results
Neuroimaging studies
(58) Experienced 
mindfulness meditators/
non-meditators
33.8 Meditators had 7.9 years of 
experience
Enhanced activation during meditation Anterior cingulate cortex (ACC) 
(self-regulation of attention and 
emotion)
(47) Students (integrative 
body-mind training vs. 
relaxation training)
21.5 5 days, 20 min a day Greater activation of the ventral and/
or rostral ACC during resting state after 
meditation
(47) Enhancement of the caudate nucleus and 
putamen during resting state following 
mindfulness meditation
Striatum (regulation of attention 
and emotion)
(41) Experienced mindfulness 
meditators vs. healthy 
non-meditators
50.5 10 years experience Reduced activation of the DMN during 
meditation
Default-mode network (brain 
network that is active in the resting 
state and inactive during task 
performance)
Stronger functional connectivity of: posterior 
cingulate, dorsal anterior cingulate, and 
dorsolateral prefrontal cortices
(59) Healthy participants 26 6 weeks, 1066 min practice 
in total
Enhanced dorsolateral PFC activation during 
an emotional Stroop task
Prefrontal cortex (PFC) (attention 
and emotion)
(60) Patients with general 
anxiety disorder vs. 
healthy controls
37.9 8-week program, once weekly, 
teacher-led group meetings plus 
one “day of mindfulness” in the 
sixth week of the course
Greater dorsolateral and dorsomedial PFC 
activation when participants were engaging 
in a mindful state while expecting to see 
negative emotional images
clinical studies
(50) Patients with ADHD 39.5 12 weekly sessions of 3 h 
MBCT, at-home practice
Reduced hyperactivity/impulsivity, as well as 
improved attention control
(61) Patients with ADHD 48.5 8 weekly sessions of 2.5 h of 
mindfulness training and daily 
at-home practice
Improvements in self-reported ADHD 
symptoms, anxiety and depression, 
improved performance on tasks measuring 
attention and cognitive inhibition
(49) Patients with ADHD 40.5 8 weekly sessions of 2.5 h of 
mindfulness training and daily 
at-home practice
Improved self-reported ADHD symptoms 
and improvement in executive functioning 
and in measured clinical ratings of ADHD 
symptoms
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ADHD. For example, a study in a non-ADHD sample compared 
the effects of an 8-week mindfulness training course in a high- vs. 
low-practice group. The results indicate that high engagement 
in mindfulness (total time practice over 8  weeks: M =  11  h, 
SD = 7 h) compared to low engagement in mindfulness (total 
time practice over 8 weeks: M = 2.5 h, SD = 1 h) is associated 
with improved working memory control and improved positive 
affect (57).
Although studies indicate that mindfulness meditation 
has positive effects on ADHD in adulthood, the exact work-
ing mechanisms of mindfulness meditation are unclear. For 
example, patients may learn to relate and react more function-
ally to their thoughts thanks to mindful awareness of their 
cognitions, or to decenter from thoughts and view them as 
passing events that do not have to be acted upon. Furthermore, 
it is possible that mindfulness meditation causes changes in 
other areas of life, such as better self-care (e.g., improved diet, 
regular exercise), which could contribute to improved treat-
ment outcomes.
cONcLUsiON
Attention-deficit/hyperactivity disorder, in adulthood is a seri-
ous mental condition with a strong neurobiological component 
that causes a wide range of impairments in affected individuals. 
Psychopharmacological medication is the first-line treatment for 
ADHD. However, not all patients respond well to it, and others 
have a preference for non-psychopharmacological treatment. 
Healthy psychological functioning in ADHD seems to rely greatly 
on the well-coordinated functioning of neuronal networks. There 
is promising preliminary evidence that mindfulness meditation 
employed as a neurobehavioral intervention in therapy can help 
ADHD patients to regulate impaired brain functioning and 
thereby improve self-regulation of attention and emotion control.
AUtHOr cONtriBUtiONs
KB: literature research and writing, AL: literature research and 
writing, AP: literature research and writing, supervision.
6Bachmann et al. MBCT and the ADHD Brain
Frontiers in Psychiatry | www.frontiersin.org June 2016 | Volume 7 | Article 117
reFereNces
1. Kessler RC, Adler LA, Barkley R, Biederman J, Conners CK, Faraone SV, et al. 
Patterns and predictors of attention-deficit/hyperactivity disorder persistence 
into adulthood: results from the national comorbidity survey replication. Biol 
Psychiatry (2005) 57(11):1442–51. doi:10.1016/j.biopsych.2005.04.001 
2. Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere 
K, et  al. Cross-national prevalence and correlates of adult attention-deficit 
hyperactivity disorder. Br J Psychiatry (2007) 190:402–9. doi:10.1192/bjp.
bp.106.034389 
3. Mostert JC, Onnink AM, Klein M, Dammers J, Harneit A, Schulten T, 
et  al. Cognitive heterogeneity in adult attention deficit/hyperactivity 
disorder: a systematic analysis of neuropsychological measurements. 
Eur Neuropsychopharmacol (2015) 25(11):2062–74. doi:10.1016/j.
euroneuro.2015.08.010 
4. Wahlstedt C, Thorell LB, Bohlin G. Heterogeneity in ADHD: neuropsycho-
logical pathways, comorbidity and symptom domains. J Abnorm Child Psychol 
(2009) 37(4):551–64. doi:10.1007/s10802-008-9286-9 
5. Castellanos FX, Proal E. Large-scale brain systems in ADHD: beyond the 
prefrontal-striatal model. Trends Cogn Sci (2012) 16(1):17–26. doi:10.1016/j.
tics.2011.11.007 
6. Durston S, van Belle J, de Zeeuw P. Differentiating frontostriatal and 
fronto-cerebellar circuits in attention-deficit/hyperactivity disorder. Biol 
Psychiatry (2011) 69(12):1178–84. doi:10.1016/j.biopsych.2010.07.037 
7. Konrad K, Herpertz S, Herpertz-Dahlmann B. Aufmerksamkeitsdefizit-
Hyperaktivitätssyndrom. In: Fink GR, Schneider F, editors. Funktionelle MRT 
in Psychiatrie und Neurologie. Berlin, Heidelberg: Springer Verlag (2013). 
p. 716–25.
8. Pitts M, Mangle L, Asherson P. Impairments, diagnosis and treatments asso-
ciated with attention-deficit/hyperactivity disorder (ADHD) in UK adults: 
results from the lifetime impairment survey. Arch Psychiatr Nurs (2015) 
29(1):56–63. doi:10.1016/j.apnu.2014.10.001 
9. NICE. Attention Deficit Hyperactivity Disorder: Diagnosis and Management 
of ADHD in Children, Young People and Adults. NICE Guideline 72. (2013). 
Available from: https://www.nice.org.uk/guidance/cg72
10. Epstein T, Patsopoulos NA, Weiser M. Immediate-release methylphenidate for 
attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database 
Syst Rev (2014) 9:Cd005041. doi:10.1002/14651858.CD005041.pub2 
11. Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW. The roles of 
dopamine and noradrenaline in the pathophysiology and treatment of atten-
tion-deficit/hyperactivity disorder. Biol Psychiatry (2011) 69(12):e145–57. 
doi:10.1016/j.biopsych.2011.02.036 
12. Krause J, Krause KH. ADHS im Erwachsenenalter: Symptome, 
Differenzialdiagnose, Therapie. Schattauer (2014).
13. ter Huurne N, Fallon SJ, van Schouwenburg M, van der Schaaf M, Buitelaar 
J, Jensen O, et  al. Methylphenidate alters selective attention by amplifying 
salience. Psychopharmacology (Berl) (2015) 232(23):4317–23. doi:10.1007/
s00213-015-4059-y 
14. Philipsen A, Jans T, Graf E, Matthies S, Borel P, Colla M, et  al. Effects of 
group psychotherapy, individual counseling, methylphenidate, and placebo 
in the treatment of adult attention-deficit/hyperactivity disorder: a random-
ized clinical trial. JAMA Psychiatry (2015) 72(12):1199–210. doi:10.1001/
jamapsychiatry.2015.2146 
15. Wilens TE, Spencer TJ, Biedermann J. A review of the pharmacotherapy of 
adults with attention-deficit/hyperactivity disorder. J Atten Disord (2002) 
5(4):189–202. doi:10.1177/108705470100500401 
16. Tucha O, Mecklinger L, Laufkotter R, Klein HE, Walitza S, Lange KW. 
Methylphenidate-induced improvements of various measures of attention in 
adults with attention deficit hyperactivity disorder. J Neural Transm (Vienna) 
(2006) 113(10):1575–92. doi:10.1007/s00702-005-0437-7 
17. Eich-Höchli D, Seifritz E, Eich P. Pharmakotherapie bei ADHS im 
Erwachsenenalter: Eine Bestandsaufnahme. Zeitschrift für Psychiatrie 
Psychologie Psychotherapie (2015) 63(1):15–24. doi:10.1024/1661-4747/
a000215 
18. Dodson WW. Pharmacotherapy of adult ADHD. J Clin Psychol (2005) 
61(5):589–606. doi:10.1002/jclp.20122 
19. Tang YY, Hölzel BK, Posner MI. The neuroscience of mindfulness meditation. 
Nat Rev Neurosci (2015) 16(4):213–25. doi:10.1038/nrn3916 
20. Kabat-Zinn J. Gesund durch Meditation: das große Buch der Selbstheilung. 
New York, NY: Otto Wilhelm Barth Verlag (2000).
21. Grawe K. Neuropsychotherapie. Göttingen: Hogrefe (2004).
22. Siegle GJ, Ghinassi F, Thase ME. Neurobehavioral therapies in the 21st century: 
summary of an emerging field and an extended example of cognitive control 
training for depression. Cognit Ther Res (2007) 31(2):235–62. doi:10.1007/
s10608-006-9118-6 
23. Morgieve M, N’Diaye K, Haynes WI, Granger B, Clair AH, Pelissolo A, 
et  al. Dynamics of psychotherapy-related cerebral haemodynamic changes 
in obsessive compulsive disorder using a personalized exposure task in 
functional magnetic resonance imaging. Psychol Med (2014) 44(7):1461–73. 
doi:10.1017/S0033291713002237 
24. Schiepek G, Tominschek I, Heinzel S, Aigner M, Dold M, Unger A, et  al. 
Discontinuous patterns of brain activation in the psychotherapy process 
of obsessive-compulsive disorder: converging results from repeated FMRI 
and daily self-reports. PLoS One (2013) 8(8):e71863. doi:10.1371/journal.
pone.0071863 
25. Chavan CF, Mouthon M, Draganski B, van der Zwaag W, Spierer L. Differential 
patterns of functional and structural plasticity within and between inferior 
frontal gyri support training-induced improvements in inhibitory control 
proficiency. Hum Brain Mapp (2015) 36(7):2527–43. doi:10.1002/hbm.22789 
26. Cortese S, Kelly C, Chabernaud C, Proal E, Di Martino A, Milham MP, et al. 
Towards systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. 
Am J Psychiatry (2012) 169(10):1038–55. doi:10.1176/appi.ajp.2012.11101521 
27. Nigg JT, Casey BJ. An integrative theory of attention-deficit/hyperactivity 
disorder based on the cognitive and affective neurosciences. Dev Psychopathol 
(2005) 17(03):785–806. doi:10.1017/S0954579405050376 
28. Cubillo A, Halari R, Smith A, Taylor E, Rubia K. A review of fronto-striatal and 
fronto-cortical brain abnormalities in children and adults with attention defi-
cit hyperactivity disorder (ADHD) and new evidence for dysfunction in adults 
with ADHD during motivation and attention. Cortex (2012) 48(2):194–215. 
doi:10.1016/j.cortex.2011.04.007 
29. Vincent JL, Kahn I, Snyder AZ, Raichle ME, Buckner RL. Evidence for a 
frontoparietal control system revealed by intrinsic functional connectivity. 
J Neurophysiol (2008) 100(6):3328–42. doi:10.1152/jn.90355.2008 
30. Menon V. Large-scale brain networks and psychopathology: a unifying 
triple network model. Trends Cogn Sci (2011) 15(10):483–506. doi:10.1016/j.
tics.2011.08.003 
31. Liston C, Matalon S, Hare TA, Davidson MC, Casey BJ. Anterior cingulate 
and posterior parietal cortices are sensitive to dissociable forms of conflict 
in a task-switching paradigm. Neuron (2006) 50(4):643–53. doi:10.1016/j.
neuron.2006.04.015 
32. Corbetta M, Patel G, Shulman GL. The reorienting system of the human 
brain: from environment to theory of mind. Neuron (2008) 58(3):306–24. 
doi:10.1016/j.neuron.2008.04.017 
33. Corbetta M, Shulman GL. Control of goal-directed and stimulus-driven atten-
tion in the brain. Nat Rev Neurosci (2002) 3(3):201–15. doi:10.1038/nrn755 
34. Ahrendts J, Rusch N, Wilke M, Philipsen A, Eickhoff SB, Glauche V, et al. 
Visual cortex abnormalities in adults with ADHD: a structural MRI study. 
World J Biol Psychiatry (2011) 12(4):260–70. doi:10.3109/15622975.2010.
518624 
35. Yeo BT, Krienen FM, Sepulcre J, Sabuncu MR, Lashkari D, Hollinshead M, 
et  al. The organization of the human cerebral cortex estimated by intrinsic 
functional connectivity. J Neurophysiol (2011) 106(3):1125–65. doi:10.1152/
jn.00338.2011 
36. Tang YY, Rothbart MK, Posner MI. Neural correlates of establishing, 
maintaining, and switching brain states. Trends Cogn Sci (2012) 16(6):330–7. 
doi:10.1016/j.tics.2012.05.001 
37. Sonuga-Barke EJ, Castellanos FX. Spontaneous attentional fluctuations 
in impaired states and pathological conditions: a neurobiological 
hypothesis. Neurosci Biobehav Rev (2007) 31(7):977–86. doi:10.1016/j.
neubiorev.2007.02.005 
38. Peterson BS, Potenza MN, Wang Z, Zhu H, Martin A, Marsh R, et al. An FMRI 
study of the effects of psychostimulants on default-mode processing during 
Stroop task performance in youths with ADHD. Am J Psychiatry (2009) 
166(11):1286–94. doi:10.1176/appi.ajp.2009.08050724 
39. Liddle EB, Hollis C, Batty MJ, Groom MJ, Totman JJ, Liotti M, et al. Task-
related default mode network modulation and inhibitory control in ADHD: 
7Bachmann et al. MBCT and the ADHD Brain
Frontiers in Psychiatry | www.frontiersin.org June 2016 | Volume 7 | Article 117
effects of motivation and methylphenidate. J Child Psychol Psychiatry (2011) 
52(7):761–71. doi:10.1111/j.1469-7610.2010.02333.x 
40. Safren SA, Sobanski E. Kognitive Verhaltenstherapie der ADHS des 
Erwachsenenalters. Berlin: Med. Wiss. Verlag-Ges (2009). 
41. Brewer JA, Worhunsky PD, Gray JR, Tang YY, Weber J, Kober H. Meditation 
experience is associated with differences in default mode network activity and 
connectivity. Proc Natl Acad Sci U S A (2011) 108(50):20254–9. doi:10.1073/
pnas.1112029108 
42. Ochsner KN, Gross JJ. The cognitive control of emotion. Trends Cogn Sci 
(2005) 9(5):242–9. doi:10.1016/j.tics.2005.03.010 
43. Wender PH. Attention-Deficit Hyperactivity Disorder in Adults. Oxford: 
Oxford University Press (1995).
44. Barkley RA, Fischer M. The unique contribution of emotional impul-
siveness to impairment in major life activities in hyperactive children 
as adults. J Am Acad Child Adolesc Psychiatry (2010) 49(5):503–13. 
doi:10.1097/00004583-201003000-00002 
45. Shaw P, Stringaris A, Nigg J, Leibenluft E. Emotional dysregulation and 
 attention-deficit/hyperactivity disorder. Am J Psychiatry (2014) 171(3):276–
93. doi:10.1176/appi.ajp.2013.13070966 
46. Tang YY, Ma Y, Wang J, Fan Y, Feng S, Lu Q, et  al. Short-term meditation 
training improves attention and self-regulation. Proc Natl Acad Sci U S A 
(2007) 104(43):17152–6. doi:10.1073/pnas.0707678104 
47. Tang YY, Ma Y, Fan Y, Feng H, Wang J, Feng S, et al. Central and autonomic 
nervous system interaction is altered by short-term meditation. Proc Natl Acad 
Sci U S A (2009) 106(22):8865–70. doi:10.1073/pnas.0904031106 
48. Gray JD, Milner TA, McEwen BS. Dynamic plasticity: the role of gluco-
corticoids, brain-derived neurotrophic factor and other trophic factors. 
Neuroscience (2013) 239:214–27. doi:10.1016/j.neuroscience.2012.08.034 
49. Mitchell JT, McIntyre EM, English JS, Dennis MF, Beckham JC, Kollins SH. 
A  pilot trial of mindfulness meditation training for attention-deficit/
hyperactivity disorder in adulthood: impact on core symptoms, exec-
utive functioning, and emotion dysregulation. J Atten Disord (2013). 
doi:10.1177/1087054713513328 
50. Schoenberg PL, Hepark S, Kan CC, Barendregt HP, Buitelaar JK, Speckens AE. 
Effects of mindfulness-based cognitive therapy on neurophysiological 
correlates of performance monitoring in adult attention-deficit/hyperac-
tivity disorder. Clin Neurophysiol (2014) 125(7):1407–16. doi:10.1016/j.
clinph.2013.11.031 
51. Mitchell JT, Zylowska L, Kollins SH. Mindfulness meditation training for 
attention-deficit/hyperactivity disorder in adulthood: current empirical 
support, treatment overview, and future directions. Cogn Behav Pract (2015) 
22(2):172–91. doi:10.1016/j.cbpra.2014.10.002 
52. Hesslinger B, Philipsen A, Richter H. Psychotherapie der ADHS im 
Erwachsenenalter: ein Arbeitsbuch. Göttingen: Hogrefe (2004).
53. Philipsen A, Richter H, Peters J, Alm B, Sobanski E, Colla M, et al. Structured 
group psychotherapy in adults with attention deficit hyperactivity disorder: 
results of an open multicentre study. J Nerv Ment Dis (2007) 195(12):1013–9. 
doi:10.1097/NMD.0b013e31815c088b 
54. Philipsen A, Hesslinger B, Tebartz van Elst L. Attention deficit hyperactivity 
disorder in adulthood: diagnosis, etiology and therapy. Dtsch Arztebl Int 
(2008) 105(17):311–7. doi:10.3238/arztebl.2008.0311 
55. Youngstrom EA, Arnold LE, Frazier TW. Bipolar and ADHD comorbidity: 
both artifact and outgrowth of shared mechanisms. Clin Psychol (New York) 
(2010) 17(4):350–9. doi:10.1111/j.1468-2850.2010.01226
56. Faraone SV, Biederman J, Wozniak J. Examining the comorbidity between 
attention deficit hyperactivity disorder and bipolar I disorder: a  meta-analysis 
of family genetic studies. Am J Psychiatry (2012) 169(12):1256–66. doi:10.1176/
appi.ajp.2012.12010087 
57. Jha AP, Stanley EA, Kiyonaga A, Wong L, Gelfand L. Examining the protective 
effects of mindfulness training on working memory capacity and affective 
experience. Emotion (2010) 10(1):54–64. doi:10.1037/a0018438 
58. Hölzel BK, Ott U, Hempel H, Hackl A, Wolf K, Stark R, et  al. Differential 
engagement of anterior cingulate and adjacent medial frontal cortex in 
adept meditators and non-meditators. Neurosci Lett (2007) 421(1):16–21. 
doi:10.1016/j.neulet.2007.04.074 
59. Allen M, Dietz M, Blair KS, van Beek M, Rees G, Vestergaard-Poulsen 
P, et  al. Cognitive-affective neural plasticity following active-controlled 
mindfulness intervention. J Neurosci (2012) 32(44):15601–10. doi:10.1523/
jneurosci.2957-12.2012 
60. Hölzel BK, Hoge EA, Greve DN, Gard T, Creswell JD, Brown KW, et al. Neural 
mechanisms of symptom improvements in generalized anxiety disorder fol-
lowing mindfulness training. Neuroimage Clin (2013) 2:448–58. doi:10.1016/j.
nicl.2013.03.011 
61. Zylowska L, Ackerman DL, Yang MH, Futrell JL, Horton NL, Hale  TS, 
et  al. Mindfulness meditation training in adults and adolescents 
with ADHD: a feasibility study. J Atten Disord (2008) 11(6):737–46. 
doi:10.1177/1087054707308502 
Conflict of Interest Statement: AP (MD) declares that she has served on advisory 
boards, given lectures, performed phase three studies, or received travel grants 
within the last 3 years from Eli Lilly and Co., Lundbeck, MEDICE Arzneimittel 
Pütter GmbH and Co. KG, Novartis, Servier, and Shire; and has authored books and 
articles on psychotherapy published by Elsevier, Hogrefe, Schattauer, Kohlhammer, 
Karger, and Springer. KB declares that the research was conducted in the absence 
of any commercial or financial relationships that could be construed as a potential 
conflict of interest. AL (MD) declares that she received travel grants within the last 
year from MEDICE Arzneimittel Pütter GmbH and Co. KG.
Copyright © 2016 Bachmann, Lam and Philipsen. This is an open-access article 
distributed under the terms of the Creative Commons Attribution License 
(CC BY). The use, distribution or reproduction in other forums is permitted, 
provided the original author(s) or licensor are credited and that the original 
publication in this journal is cited, in accordance with accepted academic prac-
tice. No use, distribution or reproduction is permitted which does not comply 
with these terms.
